Chronic Myeloid Leukemia News and Research

RSS
Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. According to the American Cancer Society, CML is a type of cancer that starts in blood-forming cells of the bone marrow and then invades the blood. It can spread to the lymph nodes, spleen, liver, and other parts of the body. CML can also change into a fast-growing acute leukemia that invades almost any organ in the body.
Discovery of novel tumor suppressor

Discovery of novel tumor suppressor

Discovery of novel tumor suppressor

Discovery of novel tumor suppressor

Protein abundant in embryonic stem cells offers a new cancer target

Protein abundant in embryonic stem cells offers a new cancer target

FDA grants full approval for Sprycel (dasatinib) for chronic myeloid leukemia

FDA grants full approval for Sprycel (dasatinib) for chronic myeloid leukemia

ChemGenex’s Omacetaxine to be showcased in three oral oresentations at EHA

ChemGenex’s Omacetaxine to be showcased in three oral oresentations at EHA

Therapeutic effect of imatinib improved with addition of chloroquine

Therapeutic effect of imatinib improved with addition of chloroquine

Enhancing the effects of imatinib mesylate used to treat chronic myeloid leukemia

Enhancing the effects of imatinib mesylate used to treat chronic myeloid leukemia

Data suggesting that omacetaxine can eradicate leukemic stem cells may offer a breakthrough for CML

Data suggesting that omacetaxine can eradicate leukemic stem cells may offer a breakthrough for CML

When less is more: Brief inhibition of cancer target is effective and less toxic

When less is more: Brief inhibition of cancer target is effective and less toxic

Researchers discover why Gleevec-type drugs control, but do not eradicate leukemia

Researchers discover why Gleevec-type drugs control, but do not eradicate leukemia

Chronic myelogenous leukemia patient survey shows that side effects are a serious issue

Chronic myelogenous leukemia patient survey shows that side effects are a serious issue

Trial shows safety of pre-transplant expansion of umbilical cord blood stem cells

Trial shows safety of pre-transplant expansion of umbilical cord blood stem cells

Trial shows Elitek significantly reduces plasma uric acid levels versus Allopurinol in adults with hematologic cancers at risk for tumor Lysis syndrome

Trial shows Elitek significantly reduces plasma uric acid levels versus Allopurinol in adults with hematologic cancers at risk for tumor Lysis syndrome

Scientists sequence genome of a cancer patient

Scientists sequence genome of a cancer patient

Gleevec holds potential as first drug to successfully treat neurofibromatosis

Gleevec holds potential as first drug to successfully treat neurofibromatosis

Discovery of mechanism and possible drug treatment for growth of nerve tumors in neurofibromatosis

Discovery of mechanism and possible drug treatment for growth of nerve tumors in neurofibromatosis

Cancer requires support from immune system to develop, researchers report

Cancer requires support from immune system to develop, researchers report

Gleevec receives FDA priority review for gastrointestinal stromal tumors after surgery

Gleevec receives FDA priority review for gastrointestinal stromal tumors after surgery

Researcher develops method for early detection of leukemia relapse

Researcher develops method for early detection of leukemia relapse

Arsenic-based agent shown to help eradicate leukemia-initiating cells

Arsenic-based agent shown to help eradicate leukemia-initiating cells

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.